TAMPA, Fla., Nov. 11, 2025 /PRNewswire/ -- Veterans Day – The Office of the Assistant Secretary of War (OASW) for…
Q3CY25 EBITDA Expansion of 154 bps YoY Q3CY25 EPS at INR 6.09, Increase of 22.3% YoY MUMBAI, India and ISELIN,…
AHMEDABAD, India, Nov. 7, 2025 /PRNewswire/ -- Senores Pharmaceuticals Limited continued its strong growth trajectory in the second quarter of FY26,…
HYDERABAD, India, Nov. 7, 2025 /PRNewswire/ -- Nava Limited, a diversified Indian multinational with interests spanning Metals, Mining, Energy, Commercial…
Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter…
LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing…
November 05, 2025 08:00 ET | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the…
Sales growth driven by launching region-specific products, expanding the distribution network, and strengthening domestic rental salesImproving quarter-on-quarter profitability through cost…
Resilient results in a complex global environment demonstrate the strength of the company’s financial model and the confidence in its…
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company…